Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Espinel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
FEMS Microbiology Letters|January 15, 1996
The inactivation of hexokinase activity does not prevent glucose repression in Candida utilisA E Espinel, V Gómez-Toribio, J M Peinado
Antimicrobial Agents and Chemotherapy|August 1, 1975
In vitro studies with combinations of 5-fluorocytosine and amphotericin BS Shadomy, G Wagner, E Espinel-Ingroff, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 14, 1985
Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysisJ Joven, C Villabona, J Rubiés-Prat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failureJ Joven, J Rubiés-Prat, E Espinel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1987
High-density lipoprotein cholesterol subfractions in chronic uremiaJ Rubiés-Prat, E Espinel, J Joven, et al.
Atherosclerosis|October 25, 1996
The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemiaJ Joven, E Espinel, J M Simó, et al.
Nephron|January 1, 1985
Apoprotein A-I and high density lipoprotein subfractions in patients with chronic renal failure receiving hemodialysisJ Joven, J Rubiés-Prat, E Espinel, et al.
Clinical Chemistry|June 1, 1995
Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuriaJ Joven, J M Simó, E Vilella, et al.
Clinical Chemistry|July 1, 1997
Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosityJ Joven, X Clivillé, J Camps, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 5, 2009
Isoflavone effect on gene expression profile and biomarkers of inflammationM Blay, A E Espinel, M A Delgado, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
FEMS Microbiology Letters|January 15, 1996
The inactivation of hexokinase activity does not prevent glucose repression in Candida utilisA E Espinel, V Gómez-Toribio, J M Peinado
Antimicrobial Agents and Chemotherapy|August 1, 1975
In vitro studies with combinations of 5-fluorocytosine and amphotericin BS Shadomy, G Wagner, E Espinel-Ingroff, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 14, 1985
Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysisJ Joven, C Villabona, J Rubiés-Prat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failureJ Joven, J Rubiés-Prat, E Espinel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1987
High-density lipoprotein cholesterol subfractions in chronic uremiaJ Rubiés-Prat, E Espinel, J Joven, et al.
Atherosclerosis|October 25, 1996
The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemiaJ Joven, E Espinel, J M Simó, et al.
Nephron|January 1, 1985
Apoprotein A-I and high density lipoprotein subfractions in patients with chronic renal failure receiving hemodialysisJ Joven, J Rubiés-Prat, E Espinel, et al.
Clinical Chemistry|June 1, 1995
Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuriaJ Joven, J M Simó, E Vilella, et al.
Clinical Chemistry|July 1, 1997
Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosityJ Joven, X Clivillé, J Camps, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 5, 2009
Isoflavone effect on gene expression profile and biomarkers of inflammationM Blay, A E Espinel, M A Delgado, et al.
Pageof 2